Background and Purpose-Intravenous thrombolysis (IVT) is beneficial in reducing disability in selected patients with acute ischemic stroke. There are numerous contraindications to IVT. One is recent surgery. The aim of this study was to analyze the safety of IVT in patients with postoperative stroke. Methods-Data of consecutive IVT patients from the Telemedical Project for Integrative Stroke Care thrombolysis registry (February 2003 to October 2014 n=4848) were retrospectively searched for keywords indicating preceding surgery. Patients were included if surgery was performed within the last 90 days before stroke. The primary outcome was defined as surgical site hemorrhage. Subgroups with major/minor surgery and recent/nonrecent surgery (within 10 days before IVT) were analyzed separately. Results-One hundred thirty-four patients underwent surgical intervention before IVT. Surgery had been performed recently (days 1-10) in 49 (37%) and nonrecently (days 11-90) in 85 patients (63%). In 86 patients (64%), surgery was classified as major, and in 48 (36%) as minor. Nine patients (7%) developed surgical site hemorrhage after IVT, of whom 4 (3%) were serious, but none was fatal. One fatal bleeding occurred remotely from surgical area. Rate of surgical site hemorrhage was significantly higher in recent than in nonrecent surgery (14.3% versus 2.4%, respectively, odds ratio adjusted 10.73; 95% confidence interval, 1.88-61.27). Difference between patients with major and minor surgeries was less distinct (8.1% and 4.2%, respectively; odds ratio adjusted 4.03; 95% confidence interval, 0.65-25.04). Overall in-hospital mortality was 8.2%. Intracranial hemorrhage occurred in 9.7% and was asymptomatic in all cases. Conclusions-IVT may be administered safely in postoperative patients as off-label use after appropriate risk-benefit assessment. However, bleeding risk in surgical area should be taken into account particularly in patients who have undergone surgery shortly before stroke onset.
I
ntravenous thrombolysis (IVT) with recombinant tissuetype plasminogen activator (tPA) within the 4.5-hour time window significantly improves the outcome of patients with acute ischemic stroke. 1 There are numerous contraindications for treatment with recombinant tPA, some of which are controversial. Some have been studied extensively and are considered as being relative contraindications, such as previous stroke and diabetes mellitus, any stroke within the last 3 months, age >80 years, and National Institute of Health Stroke Scale score <4 or >25. 2 However, the clinical relevance of some other contraindications remains controversial because of the lack of available data. One of these is the contraindication for thrombolytic treatment in postoperative stroke. It is thought that administering IVT in postoperative patients carries a significant risk of surgical site hemorrhage (SSH). The US Food and Drug Administration package insert quotes "recent major operation", and some European restrictions quote "operation within the past three months" as a contraindication. By now, mainly case reports or small case series have been published on patients with stroke receiving IVT after surgery yet. [3] [4] [5] [6] The aim of this study was to analyze the safety of IVT in a cohort of patients with stroke who had undergone surgery within the previous 90 days.
Methods

Data Collection
The Telemedical Project for Integrative Stroke Care (TEMPiS) is a TeleStroke network with 2 neurological stroke centers (hubs) and 19 regional hospitals (spokes) in Southeast Bavaria/Germany. Currently 9000 patients/y receive treatment within the network. Detailed descriptions of the concept were published previously. 7, 8 Local stroke care is provided by internal medicine departments (nonstroke specialists) in 13 hospitals and by neurological departments in 6 hospitals. All hospitals have access to stroke expertise via telemedicine 24/7. Hospitals with neurological departments use the teleconsultation service mainly to obtain a second opinion.
The TEMPiS Teleconsultation Registry is a prospective registry of all teleconsultations performed within the TEMPiS network including clinical data and recommendation on IVT.
The TEMPiS IVT registry includes all consecutive patients receiving IVT. All network hospitals use a uniform IVT protocol for documentation of times (onset, admission, and treatment), National Institute of Health Stroke Scale (NIHSS) and formal contraindications. All protocols are sent to the network coordination center for plausibility checks before entering the data into the registry. Data from February 2003 to October 2014 were searched for IVT treatment and keywords for any preceding surgery. Patients were included if surgery had been performed within 90 days before stroke. Discharge letters of all identified patients were collected from the network hospitals and reviewed.
Data security was approved by German authorities. As part of quality assurance measures, the registries did not need approval of the institutional review board.
Definitions for Subgroup Analysis
Recently and Nonrecently Performed Operations
Recently performed operations were defined as surgical interventions 1 to 10 days before IVT. When performed between day 11 and 90, surgery was defined as nonrecently.
Major and Minor Surgery
Exact definition of the terms major and minor in classifying surgery remains controversial. To reflect surgical bleeding risk, we adapted the classification as suggested by Pilcher 9 by including surgery in well-vascularized tissue (ie, colon mucosa, and prostate tissue) and surgery of large arteries in the major group.
Major Surgery
Major surgery involves opening major body cavities-abdomen (laparotomy), chest (thoracotomy), or skull (craniotomy)-or surgery in well-vascularized tissues or of any large arteries. Vital organs can be stressed. The surgery usually is done by a team of doctors using general anesthesia in a hospital operating room. A stay of at least 1 night in the hospital usually is needed after major surgery. 9 
Minor Surgery
In minor surgery, major body cavities are not opened, well-vascularized tissue or large arteries are not affected. Minor surgery can involve the use of local, regional, or general anesthesia and may be done in an emergency department, an ambulatory surgical center, or a doctor's office. Vital organs usually are not stressed, and surgery can be done by a single doctor, who may or may not be a surgeon. Usually, the person can return home on the same day that minor surgery is done. 9 All surgical procedures of our cohort were independently classified as major surgery and minor surgery by 2 of the coauthors (NV and GJH). In cases of conflicting initial categorization, agreement was sought through discussion.
If a patient had received >1 surgery within 90 days before IVT, the patient was categorized for statistical analysis to the more recent/ more serious surgery group. For example, the patient was categorized as presenting with a recent surgery if at least 1 surgery had been performed within the 10-day time window. Accordingly, the subject was categorized as presenting with a major surgery if at least 1 surgery had been major.
Outcome Measures
Primary outcome measure was SSH. Secondary outcome measures were intracranial hemorrhage (ICH), bleeding complications in other areas, and in-hospital mortality.
Definitions for Outcome Parameters
Surgical Site Hemorrhage
SSH was defined as any bleeding in the surgical wound region, along the same compartment or a nearby structure.
Bleeding Severity
Classification of bleeding severity was performed according to the Valve Academic Research Consortium. 10 Bleedings were categorized into (1) life-threatening or disabling (fatal or bleeding in critical area or bleeding causing hypovolemic shock requiring surgery or drop of hemoglobin of ≥5 g/dL per transfusion of ≥4 red blood cell units), (2) major bleeding (drop of hemoglobin of ≥3 g/dL per transfusion of 2-3 red blood cell units), and (3) minor bleeding (any bleeding worthy of clinical mention).
Intracranial Hemorrhage
Definition of asymptomatic and symptomatic ICH follows the Safe Implementation of Thrombolysis criteria. Symptomatic ICH was defined as any local or remote hemorrhage that lead to a neurological deterioration of ≥4 points on NIHSS. If NIHSS was not sufficiently documented, deterioration was estimated by evaluating the description of neurological deterioration in the patient's discharge letter.
Statistical Analysis
Data are presented as frequencies (percentages) for categorical variables. Age and NIHSS are shown as medians (interquartile range, Q1-Q3) because data were not evenly distributed. Results are displayed for the whole group and stratified for the defined subgroups as recent versus nonrecent and major versus minor surgery. Rate of SSH, ICH, other bleedings, and mortality was calculated as rate of all 134 patients. The association of time of surgery (recent versus nonrecent) and type of surgery (major versus minor) with outcomes was determined using logistic regression. In addition, a high-risk group comprising patients with surgeries that were both major and recent were compared with all other patients. Odds ratios (ORs) of all subgroup analyses were adjusted for age and sex. OR of recent versus nonrecent surgery was additionally adjusted for type of surgery, OR of major versus minor surgery for time of surgery. Both crude and adjusted OR (OR adj ) are presented with 95% confidence intervals. Statistical significance was determined at an α-level of 0.05 (2 tailed). Analyses were performed with IBM SPSS Statistics 22 (SPSS Inc, Chicago, IL).
Results
From February 2003 to October 2014, 4848 patients received tPA for stroke in the TEMPiS network. Among those, 134 were identified as having had surgical interventions within 90 days before IVT ( Figure 1 ). Patients had a median age of 75 years (interquartile range, 66-79), had a median NIHSS of 11 (interquartile range, 7-17), and were more often men (56%; Table 1; Table I in the online-only Data Supplement). Four of those patients had 2 surgical procedures within the time period (Table II in the onlineonly Data Supplement). Surgery was performed within 1 to 10 days before stroke in 49 patients (37%) and 11 to 90 days before stroke in 85 (63%). Surgery was classified as major in 86 cases (63%) and minor in 48 (36%). Types of surgery are shown in Table 2 .
In 9 patients (7%), SSH developed after IVT (Table 3) , of whom 4 (3%) were categorized as life-threatening or disabling according to Valve Academic Research Consortium and required additional intervention (transfusion of red cell concentrate, acute colonoscopy, and removal of subcutaneous hematoma). All 4 serious bleeding events occurred in patients with major surgery, none of these were fatal. One of these patients also had an eventually fatal bleeding remote from the surgical area (Table 4) .
Rate of ICH was 9.7% (13/134), all asymptomatic. Other bleeding complications occurred in 5.2% (7/134), and
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in-hospital mortality was 8.2% (11/134). Ten patients died because of severity of index ischemic stroke, 1 patient died from non-SSH gastric bleeding. Overall non-ICHs (including those in surgical areas) were found in 15 patients (11.2%). The chance of SSH was significantly higher in patients with recent than in those with nonrecent surgeries (14.3% versus 2.4%; OR adj , 10.73; 95% confidence interval, 1.88-61.27). In patients with major surgery, the rate of SSH was nonsignificantly higher than in patients with minor operations (8.1% versus 4.2%; OR adj , 4.03; 95% confidence interval, 0.65-25.04). Rate of major versus minor surgery was unequally distributed in recent and nonrecent subgroups, and statistical analysis was adjusted accordingly. There was no significant difference in intracerebral hemorrhage, other bleeding, and inhospital mortality regarding the subgroups. Highest bleeding risk was seen in patients who had surgeries that were both recent and major (21.7%; Figure 2 ). Comparing this high-risk group with all other patients showed an 8-fold higher chance of SSH development (OR adj , 8.36; 95% confidence interval, 1.82-38.48).
Discussion
In our study, stroke patients with IVT after surgery had a 6.7% risk of SSH. Serious hemorrhage only occurred in 3.0% of patients. The study group represents patients who were selected for IVT treatment on the basis of clinical judgment and risk-benefit assessment.
Previous case series have shown variable complication rates. A study on 8 patients reported no hemorrhages. 3 In another study on 13 patients who had surgery or trauma, 2 (15%) developed systemic hemorrhages after IVT. 4 And in 13 patients after cardiac surgery, 3 patients developed hemothorax or a drop in hemoglobin level after receiving intraarterial tPA. 5 These differences may be because of not only low number of patients studied but also the variable bleeding risk of each type of surgery and of each individual intraoperative situation.
In our study, non-ICHs were found in 11.2%. Published data have found 6.2% 11 and 9.6% 12 in off-label IVT patients and up to 23% in the NINDS trial (National Institute of Neurological Disorders and Stroke). 13 So, despite preceding surgery, overall non-ICHs did not differ largely from previous nonsurgical patients.
The rate of ICH was 9.7% and similar to previous publications on patients with IVT. [13] [14] [15] No hemorrhage was symptomatic according to Safe Implementation of Thrombolysis criteria. 16 One of the 7 other bleeding complications (not in surgical area and not intracranial) was fatal because of a massive gastric bleed. In this case, the operation (clipping of cerebral artery aneurysm) was 73 days ago, so it is unlikely that surgery had influenced this complication. Mortality in our study population was similar to overall mortality of patients with IVT in Bavaria, Germany (8.4%). 17 Among patients who did not experience SSH after IVT was one with carotid endarterectomy 18 days before, 2 patients with pacemaker implantations 10 and 12 days before, 1 with colonoscopy and clipping of polyps on day 1, and 1 with a biopsy of a pancreatic tumor 13 days before IVT. The study population included several patients with various abscess openings 1 to 8 days before IVT and patients with appendectomy and inguinal hernia closure 16 to 22 days before IVT. There were 2 patients with decompression of Carpal tunnel syndrome 5 and 6 days before IVT. And there were 4 patients with intramuscular injections 1 to 4 days before IVT, 7 patients receiving knee arthroscopy 5 to 25 days before IVT, and 3 patients receiving a tooth extraction 3 to 6 days before IVT. All of these patients did not experience SSH.
Risk of SSH was significantly increased when surgery had been performed recently (within 10 days before IVT). This result possibly reflects the course of surgical wound healing and general health improvement after surgery. No significant difference was found between patients with major and minor operations, with a tendency toward higher bleeding risk after major surgery. Results may be limited by the difficulties classifying major and minor surgery and by not taking into account the individual operative situation. For this study, we chose a classification that reflects postoperative bleeding risk because our primary end point was SSH. This approach does not necessarily reflect potential damage and loss of function resulting from a hemorrhage, for example, although cataract operation may be considered minor, hemorrhage in this surgical area may result in severe handicap (permanent loss of vision), whereas superficial bleeding in major orthopedic surgery may not have a long-term negative effect. Further research is warranted with functional outcome over time as primary end point and classification based on the risk of decreasing functional outcome. The elevated bleeding risk in patients with both recent and major surgery found in our 
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population should be studied further. A previous study that had administered tPA to patients early after major cardiac surgery found the bleeding rate was also high (23%).
5
Mechanical thrombectomy as a treatment option for patients with large-vessel occlusion is likely to be of even lower risk for SSH if systemic thrombolytic agents are not administered. However, data on mechanical thrombectomy in postoperative stroke patients are rare. 18 Our study has several limitations. First, it was a retrospective design with no direct control group; therefore, we do not know the bleeding risk in patients with postoperative stroke who did not receive IVT. Moreover, patients included in the study were recommended IVT after a clinical riskbenefit assessment. This study group is therefore highly selected and not representative for all patients with postoperative stroke, as we do not know the risk of SSH after IVT in patients where clinical risk-benefit assessment does not lead to thrombolysis treatment. Second, because this is a rare condition and the total rate of bleeding complications are low, the number of our study patients and low numbers of primary end points limit the statistical analysis and the interpretation of these results. Rate of major versus minor surgery was unequally distributed in recent and nonrecent subgroups, reflecting what was assumed to be a less thorough documentation of minor nonrecent surgeries in our medical records. However, adjusting for this parameter in our logistic regression model did not change significance or direction of results. Third, we did not have a long-term clinical outcome, so we are unable to determine, whether thrombolysis was beneficial in these patients, whether bleeding complications had a long-term negative effect on outcome, or whether the positive effect of IVT outweighed the complications. Bleeding in surgical area may require invasive interventions and transfusions, but may not necessarily influence overall clinical outcome. Fourth, all data come from the registry of a TeleStroke Network. This structure may have influenced the decision on whether to treat a patient with postoperative stroke and thus may have influenced the composition of the study population. Finally, because the variability of bleeding risk in different types of operations is high, generalizability to all patients with postoperative stroke is limited.
To conclude, we found an overall low risk of SSH in selected patients who received thrombolysis for postoperative stroke. SSH was higher when surgery was recent and major. In these patients, individual risk assessment is warranted before application of recombinant tPA.
